期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
经胰管胆胰管隔膜切开术及双导丝术在困难性插管ERCP中的应用及安全性分析 被引量:11
1
作者 孙雄 龚镭 +3 位作者 彭晓斌 唐学军 王小云 谈春晓 《中国内镜杂志》 北大核心 2017年第8期47-50,共4页
目的探讨经胰管胆胰管隔膜切开术及双导丝术在困难性插管内镜逆行胰胆管造影术(ERCP)中的应用及安全性。方法回顾性分析2012年1月-2014年1月行ERCP插管时选择性胆管插管困难患者158例,根据插管方法分为经胰管胆胰管隔膜切开法(A组)、双... 目的探讨经胰管胆胰管隔膜切开术及双导丝术在困难性插管内镜逆行胰胆管造影术(ERCP)中的应用及安全性。方法回顾性分析2012年1月-2014年1月行ERCP插管时选择性胆管插管困难患者158例,根据插管方法分为经胰管胆胰管隔膜切开法(A组)、双导丝法(B组)和单导丝法(C组)3组。比较三种方法插管的成功率及并发症发生率。结果 58例A组患者插管成功54例,成功率93.1%,56例B组患者插管成功50例,成功率89.3%,44例C组患者插管成功26例,成功率59.1%,A和B组成功率差异无统计学意义(P>0.05),A与C组,B与C组差异均有统计学意义(P<0.05)。A组并发胰腺炎4例,出血6例,感染2例,并发症发生率20.7%;B组并发术后胰腺炎5例,感染4例,并发症发生率16.1%;C组并发胰腺炎7例,出血2例,感染4例,并发症发生率29.5%,3组均无穿孔发生。B组并发症发生率略低于A组,但无明显差异(P>0.05),A与C组,B与C组并发症发生率均差异有统计学意义(P<0.05)。结论选择性胆管插管困难而导丝进入胰管时,继续常规单导丝插管成功率低且并发症发生率较高,经胰管乳头括约肌预切开术与双导丝法均可有效提高插管成功率,且并发症发生率均相对较低,两者之间无明显差异。 展开更多
关键词 内镜逆行胰胆管造影 经胰管乳头括约肌预切开 双导丝法 单导丝法
下载PDF
内镜黏膜下剥离术衍生技术内镜黏膜下挖除术在消化道神经内分泌肿瘤中的应用 被引量:12
2
作者 周震宇 王小云 +4 位作者 龚镭 唐学军 彭晓斌 吴高珏 胡臻 《中国内镜杂志》 2018年第4期85-89,共5页
目的探讨内镜黏膜下剥离术(ESD)衍生技术内镜黏膜下挖除术(ESE)治疗消化道神经内分泌肿瘤(NET)的安全性及其疗效。方法采用ESE方法对23例消化道NET进行治疗,术后标本送病理检查,记录不良反应发生情况及疗效,随访肿瘤复发及转移情况。结... 目的探讨内镜黏膜下剥离术(ESD)衍生技术内镜黏膜下挖除术(ESE)治疗消化道神经内分泌肿瘤(NET)的安全性及其疗效。方法采用ESE方法对23例消化道NET进行治疗,术后标本送病理检查,记录不良反应发生情况及疗效,随访肿瘤复发及转移情况。结果肿瘤直径0.4~3.0 cm,中位大小1.0 cm,均一次性完整剥离切除,ESE手术时间(自黏膜下注射至完整剥离病变)20~75 min,中位手术时间30 min,1例出现迟发性出血,1例因肿瘤侵犯固有肌层主动穿孔全层切除。术后23例病理诊断为NET,其中G1级21例、G2级2例,3例胃NET中,1型2例,2型1例,基底和切缘均未见病变累及。中位随访28个月,无1例出现肿瘤复发和转移。结论 ESE治疗消化道NET具有较好的安全性和疗效,值得在临床上推广应用。 展开更多
关键词 消化道 神经内分泌肿瘤 内镜黏膜下挖除术
下载PDF
Advanced Space-based Solar Observatory(ASO-S):an overview 被引量:28
3
作者 Wei-Qun Gan Cheng Zhu +37 位作者 Yuan-Yong Deng Hui Li Yang Su Hai-Ying Zhang Bo Chen Zhe Zhang Jian Wu Lei Deng Yu Huang Jian-Feng Yang Ji-Jun Cui Jin Chang Chi Wang Ji Wu Zeng-Shan Yin Wen Chen Cheng Fang Yi-Hua Yan Jun Lin Wei-Ming Xiong Bin Chen Hai-Chao Bao Cai-Xia Cao Yan-Ping Bai Tao Wang Bing-Long Chen Xin-Yu Li Ye Zhang Li Feng Jiang-Tao Su Ying Li Wei Chen You-Ping Li Ying-Na Su Hai-Yan Wu Mei Gu Lei Huang xue-jun tang 《Research in Astronomy and Astrophysics》 SCIE CAS CSCD 2019年第11期3-10,共8页
The Advanced Space-based Solar Observatory(ASO-S)is a mission proposed for the 25 th solar maximum by the Chinese solar community.The scientific objectives are to study the relationships between the solar magnetic fie... The Advanced Space-based Solar Observatory(ASO-S)is a mission proposed for the 25 th solar maximum by the Chinese solar community.The scientific objectives are to study the relationships between the solar magnetic field,solar flares and coronal mass ejections(CMEs).Three payloads are deployed:the Full-disk vector Magneto Graph(FMG),the Lyman-αSolar Telescope(LST)and the Hard X-ray Imager(HXI).ASO-S will perform the first simultaneous observations of the photospheric vector magnetic field,non-thermal imaging of solar flares,and the initiation and early propagation of CMEs on a single platform.ASO-S is scheduled to be launched into a 720 km Sun-synchronous orbit in 2022.This paper presents an overview of the mission till the end of Phase-B and the beginning of Phase-C. 展开更多
关键词 space vehicles instruments-Sun magnetic fields-Sun flares-Sun CMEs-Sun UV radiation-Sun X-ray gamma-rays
下载PDF
Effect of bifidobacterium triple viable powder adjuvant therapy on the inflammatory factors and t lymphocytes subsets in patients with ulcerative colitis
4
作者 xue-jun tang Xiao-Yun Wang Gao-Jue Wu 《Journal of Hainan Medical University》 2017年第12期31-34,共4页
Objective:To investigate effect of bifidobacterium triple viable powder on inflammatory factors and T lymphocyte subsets in patients with ulcerative colitis.Method:80 patients with ulcerative colitis were selected and... Objective:To investigate effect of bifidobacterium triple viable powder on inflammatory factors and T lymphocyte subsets in patients with ulcerative colitis.Method:80 patients with ulcerative colitis were selected and divided into observation group and control group, 40 cases in each group. The control group was given dietary guide, mesalazine, vitamin C and other comprehensive treatment;The observation group was given bifidobacterium triple viable powder adjuvant therapy on the basis of conventional treatment. The level of IL-6, CRP, TNF-α and T lymphocyte subsets in the two groups was compared before treatment (T0), after treatment for 1 month (T1), after treatment for 3 months (T2).Results: (1) The levels of IL-6, CRP and TNF-α at T1 serum were lower than those in T0 in both groups, the levels of serum IL-6, CRP and TNF-α at T2 were lower than those of T0 and T1, these three levels in different time points were statistical significant difference;The levels of serum IL-6, CRP and TNF-α in observation group at T1 and T2 were significantly lower than those in control group, there was significant difference in both groups;(2)The levels of CD3+, CD4+, CD4+/CD8+ at T1 were higher than T0 in two groups, The levels of CD3+, CD4+, CD4+/CD8+ at T2 were superior than at T0 and T1. The level of CD8+ at T1 was below at T0, The level of CD8+ at T2 was inferior than those in T0 and T1, The levels of CD3+,CD4+,CD8+ and CD4+/CD8+ at different time points were significant difference. The levels of CD3+, CD4+, CD4+ /CD8+ in the observation group were significantly higher than those in the control group T1 and T2, CD8+ level was significantly lower than that in the control group at T1 and T2, difference between the two groups was statistically significant.Conclusion:Bifidobacterium triple viable powder adjuvant treatment ulcerative colitis was good for inhibiting body inflammatory response and improve immune function. 展开更多
关键词 BIFIDOBACTERIUM triple viable POWDER ULCERATIVE colitis Inflammatory factors TLYMPHOCYTES
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部